Format
Sort by
Items per page

Send to

Choose Destination

Links from Books

Items: 8

1.

64Cu-Labeled human serum albumin–conjugated Affibody ZHER2:342 that targets the human epidermal growth factor receptor 2 (HER2).

Chopra A.

Molecular Imaging and Contrast Agent Database (MICAD) [Internet]. Bethesda (MD): National Center for Biotechnology Information (US); 2004-2013.
2011 May 19 [updated 2011 Jun 1].

2.

Radiolabeled affibody-albumin bioconjugates for HER2-positive cancer targeting.

Hoppmann S, Miao Z, Liu S, Liu H, Ren G, Bao A, Cheng Z.

Bioconjug Chem. 2011 Mar 16;22(3):413-21. doi: 10.1021/bc100432h. Epub 2011 Feb 7.

3.

Molecular imaging of HER2-positive breast cancer: a step toward an individualized 'image and treat' strategy.

Capala J, Bouchelouche K.

Curr Opin Oncol. 2010 Nov;22(6):559-66. doi: 10.1097/CCO.0b013e32833f8c3a. Review.

5.

Affibody molecules: engineered proteins for therapeutic, diagnostic and biotechnological applications.

Löfblom J, Feldwisch J, Tolmachev V, Carlsson J, Ståhl S, Frejd FY.

FEBS Lett. 2010 Jun 18;584(12):2670-80. doi: 10.1016/j.febslet.2010.04.014. Epub 2010 Apr 11. Review.

6.

Design of an optimized scaffold for affibody molecules.

Feldwisch J, Tolmachev V, Lendel C, Herne N, Sjöberg A, Larsson B, Rosik D, Lindqvist E, Fant G, Höidén-Guthenberg I, Galli J, Jonasson P, Abrahmsén L.

J Mol Biol. 2010 Apr 30;398(2):232-47. doi: 10.1016/j.jmb.2010.03.002. Epub 2010 Mar 10.

PMID:
20226194
7.

Imaging of HER-2 overexpression in tumors for guiding therapy.

Tolmachev V.

Curr Pharm Des. 2008;14(28):2999-3019. Review.

PMID:
18991715
8.

Recombinant human serum albumin.

Chuang VT, Otagiri M.

Drugs Today (Barc). 2007 Aug;43(8):547-61. Review.

PMID:
17925886

Supplemental Content

Support Center